ARCHIVES

NCI Encourages IP Chemo For Stage III Ovarian Cancer

This article is from The Cancer Letter archive.

Vol. 29 No. 1 | January 27, 2006

Download PDF Visit The Full Archive

Related Articles

It is The First FDA Withdrawl Of An Accelerated Approval

November 18, 2011

Conversation With The Cancer Letter: What $34,000 Per Patient Buys In Lung-MAP

June 20, 2014

Roche Reports New Avastin Results As FDA Mulls Breast Cancer Indication.

February 15, 2008

New Drugs Improve Outlook For Bone Marrow Cancer

March 31, 2006

Bunn Says ASCO Is “Strong, Diverse, Respected, Growing”

June 6, 2003

GAO Investigation Of Cancer Control Focuses On Five Contracts, Finds Alleged Deficiencies

July 18, 1980